Skip to main content
Psych Capital Plc logo

Psych Capital Plc — Investor Relations & Filings

Ticker · PSY ISIN · GB00BL6CJQ54 LEI · 213800WXCQ1C6GPLHH68 IL Professional, scientific and technical activities
Open in API
Filings indexed 62 across all filing types
Latest filing 2024-07-17 Major Shareholding Noti…
Country GB United Kingdom
Listing IL PSY

About Psych Capital Plc

https://psych.capital/

Shortwave Life Sciences Plc, formerly Psych Capital Plc, is a biopharmaceutical company that originates and develops innovative treatments for mental healthcare. The company's primary clinical program focuses on developing a psilocybin-based therapy for anorexia nervosa, a condition with no currently approved medication. It employs an IP-driven approach, leveraging global partnerships and an experienced leadership team to optimize its drug discovery and development processes. Through its subsidiary, Blossom Analysis, the company also provides a data and insights platform for the psychedelic healthcare industry.

Recent filings

Filing Released Lang Actions
TR1: Notification of Major Holdings
Major Shareholding Notification Classification · 99% confidence The document is a 'TR-1: Standard form for notification of major holdings' issued by Shortwave Life Sciences Plc on July 17, 2024. This form is specifically used to report changes in significant share ownership (crossing thresholds) to the Financial Conduct Authority (FCA) in the UK, as indicated by the RNS number, the reference to the FCA, and the structure of the form itself (which aligns with EU/UK Transparency Directive requirements). This directly corresponds to the definition of 'Major Shareholding Notification' (Code: MRQ), which covers 'Notification of changes in significant share ownership levels (crossing thresholds)'. The document is not a general regulatory announcement (RNS) but a specific disclosure mandated by ownership rules.
2024-07-17 English
Company’s Patent Claims Confirmed
Share Issue/Capital Change Classification · 99% confidence The document is an RNS announcement from Shortwave Life Sciences Plc, dated July 8, 2024. It primarily announces two things: 1) A positive International Preliminary Report on Patentability (IP confirmation) for a PCT application, which is related to Intellectual Property (IP). 2) The subsequent issuance of Deferred Consideration Shares as a condition under a previous Share Purchase Agreement (SPA) has been met. The document concludes with detailed tables showing the resulting shareholdings of directors (Roy Kait and Rivki Stern) following the share issuance. The presence of RNS Number, the structure typical of regulatory news services, and the focus on corporate actions (share issuance based on IP milestone) strongly suggest a regulatory filing. While it discusses IP, it is not a formal patent document itself, nor is it a general earnings release or annual report. The inclusion of director shareholding changes (insider dealing/transaction details) alongside the main announcement suggests it covers multiple corporate events. Given the RNS header and the nature of the announcement (corporate update/milestone achievement leading to share issuance), it fits best under the general regulatory announcement category, RNS, as it is not specifically covered by IP, DIRS, or SHA alone, but is a broad regulatory news release.
2024-07-08 English
Holding(s) in Company
Major Shareholding Notification Classification · 100% confidence The document is a standardized form titled '2TR-1: Standard form for notification of major holdings' issued by Shortwave Life Sciences Plc on July 3, 2024, via RNS (RNS Number : 0397V). The content explicitly details changes in voting rights percentages (crossing from 15.17% to 11.65%) held by a specific person (CHRISTOPHER ATUR POTTS). This type of filing, which reports changes in significant share ownership thresholds, directly corresponds to the definition of a Major Shareholding Notification. The code for this is MRQ.
2024-07-03 English
Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document is titled 'TR-1: Standard form for notification of major holdings' and is issued via 'RNS Number'. It details changes in voting rights held by a shareholder (Thomas Grant Nominees Limited) crossing a notification threshold (from 6.08% to 5.66%) on a specific date (10 June 2024). This structure is characteristic of regulatory filings concerning significant ownership changes. The closest specific category is 'Major Shareholding Notification' (MRQ). Although it is an RNS announcement, the content is specifically about a major holding change, making MRQ more precise than the general RNS fallback.
2024-06-12 English
Name Change Rebranding and Share Option Update
Regulatory Filings Classification · 100% confidence The document is identified by the 'RNS Number : 3862R' header and the concluding statement: 'This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.' This strongly indicates a regulatory announcement disseminated via the Regulatory News Service (RNS). The content primarily discusses a company name change, rebranding, and a correction regarding a share option grant. While it contains elements related to capital structure (share options) and management changes (CEO confirmation), the overarching format and distribution method classify it as a general regulatory filing. Since 'Regulatory Filings' (RNS) is the designated fallback for miscellaneous regulatory announcements not covered by more specific codes (like 10-K, ER, or DIV), this is the most appropriate classification.
2024-06-06 English
Board Resignation, Role Change and Option Grant
Board/Management Information Classification · 98% confidence The document is a formal announcement disseminated via RNS (RNS Number: 5454J) from 'Psych Capital PLC' dated April 5, 2024. The content explicitly details a change in senior management: William Potts stepping down as Chief Investment Officer and director, while remaining a Strategic Adviser. It also announces a grant of share options. This type of announcement, concerning changes in the board or senior management, directly aligns with the definition for Board/Management Information (MANG). Although it mentions share options, the primary focus is the executive role change. Since it is a specific announcement of management changes, MANG is the most appropriate code over the general fallback RNS.
2024-04-05 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.